ClinicalTrials.Veeva

Menu
T

Trustees of The University of Pennsylvania | Penn Blood Disorder Center

Research site
(Unclaimed)

Site insights

Top conditions

Parent organization

This site is a part of Trustees of The University of Pennsylvania

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 2 total trials

A Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%)

To establish baseline prospective efficacy data of current FIX prophylaxis replacement therapy in the usual care setting of hemophilia B subjects, wh...

Active, not recruiting
Hemophilia B
Hemophilia A
Drug: Standard of Care FIX Replacement therapy
Drug: Standard of Care FVIII Replacement therapy

This study will evaluate the efficacy and safety of PF-06838435 (a gene therapy drug) in adult male participants with moderately severe to severe hem...

Active, not recruiting
Hemophilia B
Biological: PF-06838435/ fidanacogene elaparvovec

Trial sponsors

Pfizer logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems